# Inhibrx Biosciences, Inc.: Form 8-K, filed Nov 14, 2024

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: 8-K
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 16:25 ET
- Period: 2024-11-14
- Accession: 0002007919-24-000060
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791924000060/inhibrx-20241114.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791924000060/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791924000060/inhibrx-20241114.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0002007919-24-000060. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
